Novartis Expands Radioligand Therapy Network with Texas Facility Groundbreaking
Novartis broke ground on a $46K sq. ft. radioligand therapy facility in Texas, the fifth RLT site supporting its $23B US manufacturing investment ending in 2028.
NVSsupply chainpersonalized medicine